An insulin pump maker is recalling certain pods that can fail to fully infuse insulin in the body. The recall comes after 18 ...

In another development, 25 states have petitioned to join a lawsuit and defend the EPA’s decision to rescind the climate endangerment finding ...

Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among those on Wegovy than among those on Ozempic.

The AI adverse event problem nobody is talking about reveals risks in FDA-cleared surgical devices lacking robust clinical trials.

Jessica Mathieson believes healthcare’s current workflow is unsustainable. Stryker’s SmartHospital platform may alleviate ...

The FDA launched The Adverse Event Monitoring System (AEMS), calling it a major achievement in the agency’s mission to modernize and provide radical transparency into the safety of regulated products.

Formula One (F1) and its governing federation, the Fédération Internationale de l'Automobile (FIA), should address the risk ...

Psilocybin works by increasing "mental flexibility," allowing patients to reframe their relationship with addiction, ...

Insulet is recalling a portion of its Omnipod 5 insulin patch pumps over a problem that could lead to under-delivery of insulin. Devices from specific lots may have a small tear in the internal tubing ...

Officials wrote that Novo Nordisk had failed to failed to report ‘serious and unexpected’ adverse drug experiences ...

Apixaban conferred lower bleeding risk during a 3-month period compared with rivaroxaban in patients with acute venous thromboembolism, researchers reported.Despite higher medication adherence to ...

After the U.S. Food and Drug Administration stopped requiring in-person visits for chemical abortions, abortion drugs became ...